Clinical features affecting the results of estrogen replacement therapy on bone density in Japanese postmenopausal women

Gynecologic and Obstetric Investigation

Volumn 52, Issue 4, 2001, Pages 223-226

  Morishige, Ken Ichirou ^a   Matsumoto, Keiko ^a   Ohmichi, Masahide ^a   Nishio, Yukihiro ^a   Adachi, Kazushige ^a   Hayakawa, Jun ^a   Nukui, Kazuhiko ^b   Tasaka, Keiichi ^a   Kurachi, Hirohisa ^c   Murata, Yuji ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b DAINIPPON SUMITOMO PHARMA CO LTD   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

Bone mineral density; Correlation analysis; Estrogen replacement therapy; Menopause

Indexed keywords

CONJUGATED ESTROGEN; MEDROXYPROGESTERONE ACETATE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG EFFECT; ESTROGEN THERAPY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; VERTEBRA;

ADULT; AGED; AGING; BONE DENSITY; BONE DISEASES, METABOLIC; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; JAPAN; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; POSTMENOPAUSE; REGRESSION ANALYSIS; SPINE; TIME FACTORS;

EID: 17944379644     PISSN: 03787346     EISSN: None     Source Type: Journal    
DOI: 10.1159/000052979     Document Type: Article

References (21)

1. Fracture protection provided by long-term estrogen treatment
2. Trial: Effects of hormone therapy on bone mineral density: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial
3. Magnitude and pattern of skeletal response to long term continuous and cyclic sequential estrogen/progestin treatment
4. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen
5. Long-term estrogen replacement therapy prevents bone loss and fractures
6. Clinical guidelines for the treatment of osteoporosis in Japan
7. Estrogen action on the bone mass of postmenopausal women is dependent on body mass and initial bone density
8. Comparison of effects of estriol on bone mineral density of vertebrae between elderly and postmenopausal women
9. Diagnostic criteria of primary osteoporosis
10. Comparing change in longitudinal studies: Adjusting for initial value
11. Monitoring osteoporosis therapy with bone densitometry
12. Estrogen treatment of patients with established postmenopausal osteoporosis
13. An assessment of hormone replacement therapy to prevent postmenopausal osteoporosis
14. Estrogen replacement therapy I: A 10-year prospective study in the relationship to osteoporosis
15. Estrogen therapy arrests bone loss in elderly women
16. The relationship of biochemical markers of bone turnover to bone density change in postmenopausal women: Results from the postmenopausal estrogen/progestin interventions (PEPI) trial
17. Decrease of bone mineral density during estrogen substitution therapy
18. Non-responders to hormone replacement therapy for the prevention of postmenopausal bone loss: Do they exist?
19. Low and conventional dose transdermal oestradiol are equally effective at preventing bone loss in spine and femur at all post-menopausal ages
20. 17β-Estradiol and continuous norethisterone: A unique treatment for established osteoporosis in elderly women
21. The effect of post-menopausal estrogen therapy on bone density in elderly women